# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 631 results.
Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients
Status: Recruiting
Last Changed: Oct 22, 2018
First Received: Jul 27, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): pembrolizumab, Azacitadine
Locations: Johns Hopkins Oncology Center, Baltimore, Maryland, United States
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Jul 10, 2018
First Received: Oct 23, 2017
Disease(s): Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia
Intervention(s): Cyclophosphamide
Locations: University of Colorado Denver, Aurora, Colorado, United States
A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Aug 10, 2018
Disease(s): Acute Myeloid Leukemia (AML)
Intervention(s): Venetoclax, Gilteritinib
Locations: David Geffen School of Medicin /ID# 200166, Los Angeles, California, United States
UC San Francisco Medical Center-Parnassus /ID# 200205, San Francisco, California, United States
Sylvester Comprehensive Cancer /ID# 200268, Miami, Florida, United States
Northwestern Memorial Hospital /ID# 200230, Chicago, Illinois, United States
Norton Cancer Institute /ID# 200623, Louisville, Kentucky, United States
... and 7 other locations.
Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients
Status: Recruiting
Last Changed: Jul 17, 2018
First Received: Mar 27, 2015
Disease(s): Acute Myeloid Leukemia
Intervention(s): Crenolanib besylate
Locations: MD Anderson Cancer Center, Houston, Texas, United States
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 09, 2019
First Received: Feb 24, 2017
Disease(s): Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult
Intervention(s): Decitabine, Bone marrow biopsy/aspirate, Peripheral blood draw, Skin biopsy, Buccal swab
Locations: University of Chicago, Chicago, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
... and 3 other locations.
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.
Status: Recruiting
Last Changed: Oct 25, 2018
First Received: Oct 17, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): NGS techniques
Locations: Hospital Reina Sofía, Córdoba, Spain
Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
Hospital 12 de Octubre, Madrid, Spain
Clínica Universidad de Navarra, Pamplona, Spain
Hospital General Universitario, Salamanca, Spain
... and 3 other locations.
A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Status: Recruiting
Last Changed: Jul 10, 2018
First Received: May 16, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): BL-8040, Atezolizumab
Locations: The University of Texas - Md Anderson Cancer Center - Leukemia Center, Houston, Texas, United States
Medical College of Wisconsin/Froedtert Hospital, Milwaukee, Wisconsin, United States
Fakultni Nemocnice Brno / University Hospital Brno Interni Hematologicka A Onkologicka Klinika / Internal Hematology and Oncology Clinic, Brno, Czechia
Fakultni Nemocnice Ostrava (Fno) / University Hospital Ostrava Klinika Hematoonkologie / Hematooncology Clinic, Ostrava, Czechia
Fakultni Nemocnice Kralovske Vinohrady Fnkv / University Hospital Kralovske Vinohrady Interní Hematologická Klinika Fnkv / Internal Hematology Clinic, Praha, Czechia
... and 8 other locations.
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Oct 17, 2018
First Received: Jul 19, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells
Locations: Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, KunMing, Yunnan, China
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Apr 01, 2019
First Received: Apr 01, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): CART-19
Locations: The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Aug 22, 2019
First Received: May 23, 2017
Disease(s): Acute Myeloid Leukemia, Myelodysplastic Syndromes
Intervention(s): Azacitidine, Decitabine, Cytarabine, Daunorubicin, Etoposide, ITMHA, Idarubicin, Fludarabine, Mitoxantrone, Erwinia asparaginase, Sorafenib, G-CSF, Dexrazoxane, Stem Cell Transplant
Locations: City of Hope Comprehensive Cancer Center, Duarte, California, United States
Children's Hospital of Central California, Madera, California, United States
Children's Hospital of Orange County, Orange, California, United States
Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
Rady Children's Hospital and Health Center, San Diego, California, United States
... and 8 other locations.